The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Open accessAbstract
ALS is a fatal motor neuron disease of adult onset. Neuroinflammation contributes to ALS disease progression; however, the inflammatory trigger remains unclear. We report that ALS–linked mutant superoxide dismutase 1 (SOD1) activates caspase-1 and IL-1β in microglia. Cytoplasmic accumulation of mutant SOD1 was sensed by an ASC containing inflammasome and antagonized by autophagy, limiting caspase-1–mediated inflammation. Notably, mutant SOD1 induced IL-1β correlated with amyloid-like misfolding and was independent of dismutase activity. Deficiency in caspase-1 or IL-1β or treatment with recombinant IL-1 receptor antagonist (IL-1RA) extended the lifespan of G93A- SOD1 transgenic mice and attenuated inflammatory pathology. These findings identify microglial IL-1β as a causative event of neuroinflammation and suggest IL-1 as a potential therapeutic target in ALS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 12×
“Disease progression in G93A-SOD1 transgenic mice is accelerated by IL-1β and can be delayed by IL-1RA treatment.”
BackgroundInfluentialHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“Furthermore, deficiency in autophagy-related 5 (ATG5), a protein required for autophagosome formation (14), increased caspase-1 activation in response to G93A-SOD1, indicating that autophagosomes were formed as a cellular stress response to remove cytoplasmic SOD1 and to reduce inflammation (Fig.”
BackgroundThe NALP3 inflammasome is involved in the innate immune response to amyloid-β
Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T. (2008) · Nature Immunology · doi:10.1038/ni.1636 · Cited by 2,441
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 1×
“These observations raise the possibility that mutant SOD1 is sensed by one ormultiple innate immune receptors that also account for the priming, analogously to the recognition of amyloid-β by an inflammasome and TLRs (5, 23, 24).”
BackgroundBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008 · cited 2×
“Neurodegeneration in ALS is accompanied by glia mediated neuroinflammation, which accelerates disease progression non–cell-autonomously (2, 4).”
BackgroundUnveiling the roles of autophagy in innate and adaptive immunity
Levine, B., & Deretic, V. (2007) · Nature Reviews Immunology · doi:10.1038/nri2161 · Cited by 906
Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model
Li, M., Ona, V. O., Guégan, C., Chen, M., Jackson-Lewis, V., Andrews, L. J., Olszewski, A. J., Stieg, P. E., Lee, J.-P., Przedborski, S., et al. (2000) · Science · doi:10.1126/science.288.5464.335 · Cited by 716
Current hypotheses for the underlying biology of amyotrophic lateral sclerosis
Rothstein, J. D. (2009) · Annals of Neurology · doi:10.1002/ana.21543 · Cited by 703 · cited 1×
“Dominant gain of function mutations of SOD1 are the most common genetic cause of ALS and also lead to motor neuron disease in mutant SOD1 transgenic mice (1).”
BackgroundHetz, C., Thielen, P., Matus, S., Nassif, M., Court, F., Kiffin, R., Martinez, G., Cuervo, A. M., Brown, R. H., & Glimcher, L. H. (2009) · Genes & Development · doi:10.1101/gad.1830709 · Cited by 530 · cited 2×
“Notably, WT SOD1-induced IL-1β release was comparable to cells primed only with LPS (13).”
BackgroundHall, E. D., Oostveen, J. A., & Gurney, M. E. (1998) · Glia · doi:10.1002/(sici)1098-1136(199807)23:3<249::aid-glia7>3.0.co;2-# · Cited by 489
Inflammatory processes in amyotrophic lateral sclerosis
McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470 · cited 4×
“IL-1 is a pleiotropic cytokine involved in the induction of inflammatory and neurotoxic molecules such as COX2, inducible NOS, NO, or IL-6, which are implicated in ALS (4, 16, 18, 26).”
BackgroundInfluentialUrushitani, M., Sik, A., Sakurai, T., Nukina, N., Takahashi, R., & Julien, J.-P. (2006) · Nature Neuroscience · doi:10.1038/nn1603 · Cited by 419
Inflammasomes: guardians of cytosolic sanctity
Lamkanfi, M., & Dixit, V. M. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00730.x · Cited by 361
Pasinelli, P., Houseweart, M. K., Brown, R. H., & Cleveland, D. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240305897 · Cited by 345
Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury
Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J., & Appel, S. H. (2010) · Glia · doi:10.1002/glia.20919 · Cited by 288
Prudencio, M., Hart, P. J., Borchelt, D. R., & Andersen, P. M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp260 · Cited by 255
An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS
Rakhit, R., Robertson, J., Velde, C. V., Horne, P., Ruth, D. M., Griffin, J., Cleveland, D. W., Cashman, N. R., & Chakrabartty, A. (2007) · Nature Medicine · doi:10.1038/nm1559 · Cited by 230
Responses to Amyloids of Microbial and Host Origin Are Mediated through Toll-like Receptor 2
Tükel, Ç., Wilson, R. P., Nishimori, J. H., Pezeshki, M., Chromy, B. A., & Bäumler, A. J. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.020 · Cited by 182
Zetterström, P., Stewart, H. G., Bergemalm, D., Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brännström, T., Oliveberg, M., & Marklund, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700477104 · Cited by 170
Aggregation of Copper–Zinc Superoxide Dismutase in Familial and Sporadic ALS
Chattopadhyay, M., & Valentine, J. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2536 · Cited by 163 · cited 2×
“Mutations prompt SOD1 tomisfold into amyloid-like structures in vitro and in vivo (3).”
BackgroundInnate immunity in amyotrophic lateral sclerosis
Moisse, K., & Strong, M. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.001 · Cited by 157
Nguyen, M. D., Julien, J., & Rivest, S. (2001) · Annals of Neurology · doi:10.1002/ana.1256 · Cited by 141
Habisch, H., Janowski, M., Binder, D., Kuzma-Kozakiewicz, M., Widmann, A., Habich, A., Schwalenstöcker, B., Hermann, A., Brenner, R. E., Łukomska, B., et al. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0748-y · Cited by 122
Hensley, K., Abdel-Moaty, H., Hunter, J., Mhatre, M., Mou, S., Nguyen, K. L., Potapova, T., Pye, Q. N., Qi, M., Rice, H. C., et al. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-2 · Cited by 105
Role of Caspase 1 in Neurologic Disease
Friedlander, R. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.9.1273 · Cited by 35
Cited by
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Autophagy in immunity and inflammation
Levine, B., Mizushima, N., & Virgin, H. W. (2011) · Nature · doi:10.1038/nature09782 · Cited by 3,289
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Microglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Metadata
- Authors
- Meissner, F., Molawi, K., & Zychlinsky, A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-07-20
- Volume
- 107
- Issue
- 29
- Pages
- 13046-13050
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2077331144
- Cited by
- 318
- References
- 28
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.